Literature DB >> 16478733

Polo box domain of Plk3 functions as a centrosome localization signal, overexpression of which causes mitotic arrest, cytokinesis defects, and apoptosis.

Ning Jiang1, Xiaoxing Wang, Meena Jhanwar-Uniyal, Zbigniew Darzynkiewicz, Wei Dai.   

Abstract

Polo-like kinase 3 (Plk3), an immediate early response gene product, plays an important role in the regulation of mitosis, DNA damage checkpoint activation, and Golgi dynamics. Similar to other members of the Plk family, Plk3 has a conserved kinase domain at the N terminus and a Polo box domain consisting of two Polo boxes at the C terminus. In this study, we demonstrate that the Polo box domain of Plk3 is sufficient for subcellular localization of this kinase to the centrosomes, the spindle poles, and the midbody when ectopically expressed in HeLa and U2OS cells. Both Polo boxes are required for the subcellular localization. Overexpression of the Polo box domain, not the kinase domain, of Plk3 causes significant cell cycle arrest and cytokinesis defects, eventually leading to mitotic catastrophe/apoptosis. Interestingly, the Polo box domain of Plk3 is more potent in inhibiting cell proliferation and inducing apoptosis than that of Plk1, suggesting that this domain can provide an additional structural basis for discovery of new anticancer drugs given the current emphasis on Plk1 as a therapeutic target.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16478733     DOI: 10.1074/jbc.M513156200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  Effect of hypoxic stress-activated Polo-like kinase 3 on corneal epithelial wound healing.

Authors:  Jiawei Lu; Ling Wang; Wei Dai; Luo Lu
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-05-26       Impact factor: 4.799

2.  Plk3 interacts with and specifically phosphorylates VRK1 in Ser342, a downstream target in a pathway that induces Golgi fragmentation.

Authors:  Inmaculada López-Sánchez; Marta Sanz-García; Pedro A Lazo
Journal:  Mol Cell Biol       Date:  2008-12-22       Impact factor: 4.272

3.  Phosphorylation of p53 on Ser15 during cell cycle caused by Topo I and Topo II inhibitors in relation to ATM and Chk2 activation.

Authors:  Hong Zhao; Frank Traganos; Zbigniew Darzynkiewicz
Journal:  Cell Cycle       Date:  2008-10-06       Impact factor: 4.534

4.  Role of senescence and mitotic catastrophe in cancer therapy.

Authors:  Richa Singh; Jasmine George; Yogeshwer Shukla
Journal:  Cell Div       Date:  2010-01-21       Impact factor: 5.130

Review 5.  Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy.

Authors:  Klaus Strebhardt
Journal:  Nat Rev Drug Discov       Date:  2010-08       Impact factor: 84.694

6.  The role of polo-like kinase 3 in the response of BRAF-mutant cells to targeted anticancer therapies.

Authors:  Mahamat Babagana; Julia V Kichina; Hannah Slabodkin; Sydney Johnson; Alexei Maslov; Lorin Brown; Kristopher Attwood; Mikhail A Nikiforov; Eugene S Kandel
Journal:  Mol Carcinog       Date:  2019-09-30       Impact factor: 4.784

Review 7.  The role of Plk3 in oncogenesis.

Authors:  C Helmke; S Becker; K Strebhardt
Journal:  Oncogene       Date:  2015-04-27       Impact factor: 9.867

8.  Determination of genes and microRNAs involved in the resistance to fludarabine in vivo in chronic lymphocytic leukemia.

Authors:  Etienne Moussay; Valérie Palissot; Laurent Vallar; Hélène A Poirel; Thomas Wenner; Victoria El Khoury; Nasséra Aouali; Kris Van Moer; Bernadette Leners; François Bernardin; Arnaud Muller; Pascale Cornillet-Lefebvre; Alain Delmer; Caroline Duhem; Fernand Ries; Eric van Dyck; Guy Berchem
Journal:  Mol Cancer       Date:  2010-05-20       Impact factor: 27.401

Review 9.  The Golgi and the centrosome: building a functional partnership.

Authors:  Christine Sütterlin; Antonino Colanzi
Journal:  J Cell Biol       Date:  2010-03-08       Impact factor: 10.539

10.  Activity-induced Polo-like kinase 2 is required for homeostatic plasticity of hippocampal neurons during epileptiform activity.

Authors:  Daniel P Seeburg; Morgan Sheng
Journal:  J Neurosci       Date:  2008-06-25       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.